Venlo, The Netherlands, and Hombrechtikon, Switzerland, Sept. 25, 2024 (GLOBE NEWSWIRE) -- PreAnalytiX GmbH, a joint venture between QIAGEN N.V.

FRANKLIN LAKES, N.J., May 13, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the industry’s first self ...

(RTTNews) - Becton, Dickinson and Company (BDX) has received 510(k) clearance from the FDA for the BD Kiestra IdentifA system, which is designed to automate the preparation of microbiology ...

Becton Dickinson has received 510(k) clearance for a device that collects blood from a fingerstick instead of from the vein. The MiniDraw Capillary Blood Collection System container is slightly ...

Becton, Dickinson and Company BDX, also popularly known as BD, recently introduced its new fully-automated, high-throughput infectious disease molecular diagnostics platform in the United States.

BD, a leading global medical technology company, announced today that it obtained the CE mark in Europe for a next-generation blood separation technology that is designed to enhance sample quality ...

BD today announced the completion of its acquisition of HandyLab, Inc., an Ann Arbor, Michigan-based company that develops and manufactures molecular diagnostic assays and automation platforms.

PAXgene Urine Liquid Biopsy Set with collection cup and a nucleic acid stabilizing tube enables non-invasive sample collection and direct cell-free DNA stabilization from urine // QIAGEN to ...